The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Open accessAbstract
Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery, clinical medicine and research, as well as in other varied sciences. Due to their unique size-dependent properties, lipid nanoparticles offer the possibility to develop new therapeutics. The ability to incorporate drugs into nanocarriers offers a new prototype in drug delivery that could be used for secondary and tertiary levels of drug targeting. Hence, solid lipid nanoparticles hold great promise for reaching the goal of controlled and site specific drug delivery and hence have attracted wide attention of researchers. This review presents a broad treatment of solid lipid nanoparticles discussing their advantages, limitations and their possible remedies. The different types of nanocarriers which were based on solid lipid like solid lipid nanoparticles, nanostructured lipid carriers, lipid drug conjugates are discussed with their structural differences. Different production methods which are suitable for large scale production and applications of solid lipid nanoparticles are described. Appropriate analytical techniques for characterization of solid lipid nanoparticles like photon correlation spectroscopy, scanning electron microscopy, differential scanning calorimetry are highlighted. Aspects of solid lipid nanoparticles route of administration and their biodistribution are also incorporated. If appropriately investigated, solid lipid nanoparticles may open new vistas in therapy of complex diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Imaging Crystals, Polymers, and Processes in Water with the Atomic Force Microscope
Drake, B., Prater, C. B., Weisenhorn, A. L., Gould, S. A. C., Albrecht, T. R., Quate, C. F., Cannell, D. S., Hansma, H. G., & Hansma, P. K. (1989) · Science · doi:10.1126/science.2928794 · Cited by 1,033
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
(1996) · Handbook of Microscopy · doi:10.1002/9783527620524.ch13 · Cited by 726
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 545
Jenning, V., Gysler, A., Schäfer-Korting, M., & Gohla, S. H. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00075-2 · Cited by 528
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery
Liu, J., Hu, W., Chen, H., Ni, Q., Xu, H., & Yang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.007 · Cited by 384
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting
Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H., & Yang, X. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.052 · Cited by 323
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Lai, F., Wissing, S. A., Müller, R. H., & Fadda, A. M. (2006) · AAPS PharmSciTech · doi:10.1208/pt070102 · Cited by 266
Production of lipospheres as carriers for bioactive compounds
Cortesi, R. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00362-3 · Cited by 233
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
SLN and NLC for topical delivery of ketoconazole
Souto, E. B., & Müller, R. H. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500162436 · Cited by 208
Albumin microspheres for study of the reticuloendothelial system.
Scheffel, U., Rhodes, B. A., Natarajan, T. K., & Wagner, H. N. (1972) · PubMed · Cited by 207
Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
Wissing, S. A., Lippacher, A., & Müller, R. (2001) · PubMed · Cited by 199
Submicron Emulsions in Drug Targeting and Delivery
(2019) · CRC Press eBooks · doi:10.1201/9780367810528 · Cited by 199
Drug Targeting by Solid Lipid Nanoparticles for Dermal Use
Santos Maia, C., Mehnert, W., Schaller, M., Korting, H. C., Gysler, A., Haberland, A., & Schäfer-korting, M. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000038364 · Cited by 186
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Eldem, T., Speiser, P., & Hincal, A. (1991) · Pharmaceutical Research · doi:10.1023/a:1015874121860 · Cited by 165
Souto, E. B., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040500435295 · Cited by 159
Gaulin Homogenization: A Mechanistic Study
Lander, R., Manger, W., Scouloudis, M., Ku, A., Davis, C., & Lee, A. (2000) · Biotechnology Progress · doi:10.1021/bp990135c · Cited by 141
Lu, B., Xiong, S.-B., Yang, H., Yin, X., & Ruo-bing, C. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.001 · Cited by 136
Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
Wissing, S. A., & Müller, R. H. (2001) · PubMed · Cited by 124
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
Siekmann, B., & Westesen, K. (1996) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 123
Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Müller, R. H., & Rosenecker, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041463.56768.ec · Cited by 119
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 117
Polymorphic properties of micronized carbamazepine produced by RESS
Gosselin, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00649-x · Cited by 113
Morel, S., Terreno, E., Ugazio, E., Aime, S., & Gasco, M. R. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00107-0 · Cited by 97
Solid Lipid Nanoparticles Bearing Flurbiprofen for Transdermal Delivery
Jain, S., Chourasia, M. K., Masuriha, R., Soni, V., Jain, A., Jain, N. K., & Gupta, Y. (2005) · Drug Delivery · doi:10.1080/10717540590952591 · Cited by 96
Jumaa, M., & Müller, B. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00071-8 · Cited by 96
Ahlin, P., Kristl, J., & Šmid-Korbar, J. (1998) · Acta Pharmaceutica · Cited by 89
Effects of some experimental factors on the production process of solid lipid nanoparticles
Cavalli, R., Marengo, E., Rodrı́guez, L., & Gasco, M. R. (1996) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 89
The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
Souto, E. B., & Müller, R. H. (2006) · PubMed · Cited by 83
Methotrexate Loaded Solid Lipid Nanoparticles (SLN) for Effective Treatment of Carcinoma
Kandasamy, R., Manickam, S., & Ganeshkumar, P. A. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.457 · Cited by 80
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery
Hayes, M. E., Drummond, D. C., Kirpotin, D. B., Zheng, W. W., Noble, C. O., Park, J. W., Marks, J. D., Benz, C. C., & Hong, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302699 · Cited by 77
Triptolide Loaded Solid Lipid Nanoparticle Hydrogel for Topical Application
Mei, Z., Qun-rong, W., Hu, S., Lib, X., & Yang, X. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-200047791 · Cited by 75
Construction, gene delivery, and expression of DNA tethered nanoparticles.
Prow, T. W., Smith, J. N., Grebe, R. R., Salazar, J. H., Wang, N., Kotov, N. A., Lutty, G. A., & Leary, J. F. (2006) · PubMed · Cited by 69
Pharmaceutical applications of supercritical carbon dioxide.
Kaiser, C., Römpp, H., & Schmidt, P. C. (2001) · PubMed · Cited by 44
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions
Sjöström, B., Westesen, K., & Bergenståhl, B. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90013-6 · Cited by 42
Chen, Y., Jin, R.-X., Zhou, Y., Zeng, J., Zhang, H., & Feng, Q.-R. (2006) · PubMed · Cited by 32
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040191 · Cited by 669
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Metadata
- Authors
- Mukherjee, S., Ray, S., & Thakur, R.
- Venue
- Indian Journal of Pharmaceutical Sciences
- Publisher
- OMICS Publishing Group
- Published
- 2009
- Volume
- 71
- Issue
- 4
- Pages
- 349
- ISSN
- 0250-474X (ISSN-L)
- OpenAlex
- W2044903986
- Cited by
- 1,000
- References
- 50
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.